Amicus Therapeutics Inc. buy Needham & Company LLC
Start price
18.09.25
/
50%
€7.20
Target price
18.09.26
€11.85
Performance (%)
-0.69%
Price
09.10.25
€7.05
Summary
This prediction is currently active. Since the start of the prediction for Amicus Therapeutics Inc. the price has only changed by -0.69%. This prediction currently runs until 18.09.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Amicus Therapeutics Inc. | 0.714% |
| iShares Core DAX® | -0.693% |
| iShares Nasdaq 100 | -1.173% |
| iShares Nikkei 225® | -1.388% |
| iShares S&P 500 | -1.411% |
Comments by Needham___Company_LL for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics (NASDAQ:FOLD) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat